Genetic and Biochemical Markers of Interferon-Induced Depression.
NCT00252538 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 133
Last updated 2014-12-11
Summary
The purpose of this study is to identify predictors and associated biochemical markers of interferon-induced depression. It is hypothesized that genetic variation in genes related to the serotonergic system may predict vulnerability to interferon-induced depression.
Conditions
Sponsors & Collaborators
-
US Department of Veterans Affairs
lead FED
Principal Investigators
-
Peter Hauser, MD · VA Medical Center, Long Beach
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-04-30
- Primary Completion
- 2009-09-30
- Completion
- 2009-09-30
Countries
- United States
Study Locations
More Related Trials
-
Serum Markers as a Bioassay for Unipolar Depression
NCT00825799 ·Status: COMPLETED
-
Predictors of Depression Treatment Response to Exercise
NCT02583867 ·Status: COMPLETED ·Phase: PHASE3
-
Influenza Vaccine as a Novel Experimental Model of the Behavioral Immune Response in Depression
NCT03756246 ·Status: UNKNOWN ·Phase: PHASE4
-
DNA-based Dietary Advice for Adults With Depressive Disorders
NCT03310827 ·Status: UNKNOWN ·Phase: NA
-
Incidence of Metabolic Syndrome and Thyroid Dysfunction in Patients With Major Depressive Disorder
NCT01682785 ·Status: UNKNOWN
-
Association of Peripheral Immune Cells With Antidepressant Treatment Response
NCT06182722 ·Status: RECRUITING
-
Clinical and Biological Markers of Response to Cognitive Behavioural Therapy for Depression
NCT02883257 ·Status: COMPLETED ·Phase: NA
-
Canadian Biomarker Integration Network for Depression Study
NCT01655706 ·Status: COMPLETED ·Phase: PHASE3
-
Assessing Treatment Emergent Suicidal Ideation in Patients With Major Depression
NCT00532103 ·Status: COMPLETED
-
Gut Microbiome and Depression
NCT05808101 ·Status: TERMINATED
-
Study of the Telomere-telomerase System and the Expression of Candidate Genes in the Leukocytes of Patients With Depressive Disorder: Search for Peripheral Markers of Somatic Stress
NCT01903655 ·Status: COMPLETED ·Phase: NA
-
Exploratory Study on the Mood and Cytokine Levels in Female Healthy Participants and Major Depressive Disorder Patients
NCT01533285 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Cellular Aging and Neurobiology of Depression Study
NCT00285935 ·Status: COMPLETED ·Phase: NA
-
Noninvasive Physiologic Sensors to Assess Depression
NCT02568865 ·Status: COMPLETED
-
Peripheral Immunomarker Validation in Treatment-resistant Depression
NCT02752178 ·Status: COMPLETED
-
Major Depression and Inflammatory Risk Markers for Coronary Heart Disease
NCT00037505 ·Status: COMPLETED
-
Organized Self-Management Support Services for Chronic Depression
NCT01139060 ·Status: COMPLETED ·Phase: PHASE3
-
Stress and Inflammation in Late-Life Depression
NCT02389465 ·Status: COMPLETED ·Phase: PHASE4
-
Studying Patterns in Patient Engagement Among Treatment Resistant Depression Patients
NCT06101914 ·Status: NOT_YET_RECRUITING
-
Blood Biomarkers in Major Depression
NCT02209142 ·Status: COMPLETED ·Phase: NA
-
Impact of Depression on Thermoregulation
NCT06805851 ·Status: RECRUITING
-
Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab
NCT06136546 ·Status: RECRUITING ·Phase: PHASE2
-
Major Depression and Messenger RNAs
NCT00998231 ·Status: COMPLETED ·Phase: NA
-
Model-based Defining of Subtypes of Depression and Optimal Treatment: an Integrated Techniques Module.
NCT04518592 ·Status: RECRUITING
-
Exploring Clinical Study Experiences of People With Depression
NCT05937932 ·Status: NOT_YET_RECRUITING